Philadelphia Endocrine Society
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 51,119 | 41,220 | 9,899 | 8.6 | — |
| 2012 | 85,974 | 42,987 | 42,987 | 20.3 | — |
| 2013 | 59,478 | 43,833 | 15,645 | 24.2 | — |
| 2014 | 92,703 | 53,030 | 39,673 | 28.9 | — |
| 2015 | 125,786 | 55,755 | 70,031 | 42.6 | — |
| 2016 | 135,409 | 78,251 | 57,158 | 39.1 | — |
| 2017 | 158,253 | 71,579 | 86,674 | 57.3 | — |
| 2018 | 144,577 | 72,056 | 72,521 | 69.0 | — |
| 2019 | 128,973 | 86,355 | 42,618 | 63.5 | — |
| 2020 | 68,229 | 44,541 | 23,688 | 129.5 | — |
| 2021 | 57,949 | 42,516 | 15,433 | 140.0 | 0% |
| 2022 | 101,880 | 82,205 | 19,675 | 75.3 | 0% |
| 2023 | 173,701 | 103,125 | 70,576 | 68.2 | 0% |
In its most recent public year (2023), this organization brought in $70,576 more than it spent. Its reserves stood at about 68.2 months of spending, up from 8.6 in 2011. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Philadelphia Endocrine Society's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works